HIV/AIDS

December 10, 2020

HIV patients stay away after Nigerian clinic introduces fees

Six years ago, in Nigeria, funding cutbacks for HIV treatment and the consequent introduction of patient fees were associated with sharp declines in new HIV clinic enrollments and patient adherence to antiretroviral therapy (ART).

By Paul Govern
November 2, 2020

Frog peptides as anti-HIV microbicides

Peptides derived from the antimicrobial peptides secreted by frogs could function as microbicides to limit HIV transmission, while sparing protective vaginal bacteria.

By Leigh MacMillan
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

By Bill Snyder
September 17, 2020

HIV prevention medication not being prescribed routinely: study

Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.

By Jake Lowary
August 25, 2020

The Vanderbilt doctor who told his story of battling AIDS on “60 Minutes”

He wrote a bestseller, was interviewed on “60 Minutes,” and his story showed a more hopeful future for people infected with HIV

By Wayne Wood
June 24, 2020

Study finds zinc doesn’t reduce mortality, other health risks, for heavy alcohol users living with HIV/AIDS

Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study.

By Matt Batcheldor
June 9, 2020

VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.
By Kristin Centers
May 7, 2020

Center for AIDS Research lands NIH grant renewal

The National Institutes of Health (NIH) has renewed its support of the Tennessee Center for AIDS Research (CFAR), a four-way partnership between Vanderbilt University Medical Center, Meharry Medical College, the Tennessee Department of Health and Nashville CARES.
By Bill Snyder
May 7, 2020

Team to test app for improving HIV care for new mothers in South Africa

As South Africans with HIV move around the country, there is a risk they will disengage from the health care system or otherwise become lost to follow-up care.
By Paul Govern
December 12, 2019

Study examines HIV drug’s potential to treat Alzheimer’s

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease.
By Bill Snyder
November 27, 2019

In 1994, Harold “Scottie” Scott’s HIV-positive status was covered on the local news. He has been an educator ever since.

Now, 25 years after his announcement, Scott’s mission remains the same: to educate others on the history of HIV, dispel myths and break down stigma.
By Kelsey Herbers
November 6, 2019

HIV/AIDS expert Nabel set for next Discovery Lecture

Gary Nabel, MD, PhD, Chief Scientific Officer and Senior Vice President of Sanofi, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 14.
By Leigh MacMillan
July 24, 2019

Major grant renews AIDS education, training initiative

VUMC has been awarded a five-year, nearly $23 million federal grant to continue coordinating AIDS education and training efforts in Tennessee and seven other southeastern states.
By Bill Snyder
1 2 3 4 5 … 8